We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70
Avg Time Held
12 quarters
Top 10 Avg Time Held
12 quarters
Top 20 Avg Time Held
10.4 quarters

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
URG icon
1301
Ur-Energy
URG
$354M
$24.8K ﹤0.01%
+17,685
New +$29.3K
2024 Q2
0 quarters
OCGN icon
1302
Ocugen
OCGN
$300M
$24.6K ﹤0.01%
+15,861
New +$24.7K
2024 Q2
0 quarters
PACB icon
1303
Pacific Biosciences
PACB
$637M
$24.1K ﹤0.01%
17,594
+2,249
+15% +$4.54K
2022 Q2
8 quarters
FUBO icon
1304
FuboTV Inc
FUBO
$247M
$23.4K ﹤0.01%
1,575
+167
+12% +$2.67K
2022 Q3
7 quarters
CIG icon
1305
CEMIG Preferred Shares
CIG
$6.69B
$21.3K ﹤0.01%
+12,112
New +$23.2K
2024 Q2
0 quarters
CERS icon
1306
Cerus
CERS
$455M
$20.2K ﹤0.01%
11,460
+1,092
+11% +$1.95K
2023 Q2
4 quarters
PL icon
1307
Planet Labs
PL
$5.52B
$18.8K ﹤0.01%
10,108
-349
-3% -$669
2023 Q4
2 quarters
FCEL icon
1308
FuelCell Energy
FCEL
$1.24B
$18.6K ﹤0.01%
972
+84
+9% +$2.25K
2021 Q2
12 quarters
IAUX icon
1309
i-80 Gold Corp
IAUX
$1.33B
$16.7K ﹤0.01%
15,430
+3,705
+32% +$4.34K
2023 Q2
4 quarters
VISN icon
1310
Vistance Networks Inc
VISN
$1.41B
$15.9K ﹤0.01%
12,918
+596
+5% +$709
2021 Q2
12 quarters
EAF icon
1311
GrafTech
EAF
$214M
$14.7K ﹤0.01%
1,513
+339
+29% +$5.21K
2022 Q2
8 quarters
LYEL icon
1312
Lyell Immunopharma
LYEL
$184M
$14.6K ﹤0.01%
503
-31
-6% -$1.48K
2023 Q3
3 quarters
NKTR icon
1313
Nektar Therapeutics
NKTR
$1.29B
$14.2K ﹤0.01%
+764
New +$16.1K
2024 Q2
0 quarters
AKBA icon
1314
Akebia Therapeutics
AKBA
$213M
$14K ﹤0.01%
+13,701
New +$16.9K
2024 Q2
0 quarters
MVIS icon
1315
Microvision
MVIS
$36.1M
$13.6K ﹤0.01%
856
+105
+14% +$2.07K
2023 Q2
4 quarters
BLUE icon
1316
DELISTED
bluebird bio
BLUE
$11.7K ﹤0.01%
592
– –
2024 Q1
1 quarter
AAP icon
1317
Advance Auto Parts
AAP
$2.53B
– –
-2,829
Closed -$241K –
AGEN icon
1318
Agenus
AGEN
$314M
– –
-1,151
Closed -$13.3K –
AGO icon
1319
Assured Guaranty
AGO
$3.06B
– –
-2,816
Closed -$246K –
ALRM icon
1320
Alarm.com
ALRM
$2.76B
– –
-2,914
Closed -$211K –
AMBP icon
1321
Ardagh Metal Packaging
AMBP
$2.59B
– –
-19,000
Closed -$65.2K –
AMWL icon
1322
American Well
AMWL
$207M
– –
-760
Closed -$12.3K –
ARCB icon
1323
ArcBest
ARCB
$2.91B
– –
-1,447
Closed -$206K –
BANC icon
1324
Banc of California
BANC
$2.72B
– –
-22,855
Closed -$348K –
BF.A icon
1325
Brown-Forman Class A
BF.A
$12.8B
– –
-5,155
Closed -$273K –
51 52
53
54 55

Similar funds

PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
BS
Banco Santander Madrid, Spain $16.1B AUM 35.02% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $16.1B AUM 40.83% 1-Year Est. Return
NMO
Newlands Management Operations Dallas, Texas $16.6B AUM 3.91% 1-Year Est. Return
PAS
Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.